SK Bioscience to raise $1.3b in S Korea's largest IPO since 2017

SK Bioscience to raise $1.3b in S Korea's largest IPO since 2017

Photo by Louis Reed on Unsplash

South Korean vaccine developer SK Bioscience Co Ltd is expected to raise 1.5 trillion won ($1.33 billion) in the country’s largest IPO since 2017, after pricing the listing at the top of an indicative range, it said on Monday.